Advertisement
Clinical Reviews| Volume 64, ISSUE 2, P156-166, February 2023

Interstitial Lung Disease: A Focused Review for the Emergency Clinician

      Abstract

      Background

      Interstitial lung disease (ILD) is a group of restrictive pulmonary diseases associated with diffuse interstitial and parenchymal inflammation. Patients can present to the emergency department with severe exacerbation.

      Objective

      This narrative review provides emergency clinicians with the most recent evidence concerning acute exacerbation of ILD (AE-ILD).

      Discussion

      AE-ILD can present as acute respiratory distress in a patient with a pre-existing ILD diagnosis or as a de novo presentation of ILD, and is associated with significant morbidity and mortality. A variety of underlying triggers may result in AE-ILD. Emergency clinicians must first assess for extraneous causes of respiratory decompensation prior to diagnosing AE-ILD. For a de novo presentation of ILD, emergency physicians should also assess for possible reversible causes. AE-ILD is managed with systemic steroids, immunosuppressants, intravenous antibiotics, supplemental oxygen, and extracorporeal membrane oxygenation in severe cases. Given the high mortality rates in the absence of lung transplantation, early referral to transplant centers is essential to increase chances of survival.

      Conclusions

      Emergency clinician knowledge of AE-ILD can improve the evaluation and management of these patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Raghu G
        • Collard HR
        • Egan JJ
        • et al.
        An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
        Am J Respir Crit Care Med. 2011; 183: 788-824
        • King TE
        • Pardo A
        • Selman M.
        Idiopathic pulmonary fibrosis.
        Lancet. 2011; 378: 1949-1961
        • Travis WD
        • Hunninghake G
        • King TE
        • et al.
        Idiopathic nonspecific interstitial pneumonia.
        Am J Respir Crit Care Med. 2008; 177: 1338-1347
        • Travis WD
        • Costabel U
        • Hansell DM
        • et al.
        An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
        Am J Respir Crit Care Med. 2013; 188: 733-748
        • Raghu G
        • Remy-Jardin M
        • Myers JL
        • et al.
        Diagnosis of idiopathic pulmonary fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
        Am J Respir Crit Care Med. 2018; 198: e44-e68
        • American Thoracic Society; European Respiratory Society
        American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.
        Am J Respir Crit Care Med. 2002; 165: 277-304
        • Bradley B
        • Branley HM
        • Egan JJ
        • et al.
        Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.
        Thorax. 2008; 63: v1-58
        • Mikolasch TA
        • Garthwaite HS
        • Porter JC.
        Update in diagnosis and management of interstitial lung disease.
        Clin Med. 2016; 16: s71-s78
        • Kim R
        • Meyer KC.
        Review: therapies for interstitial lung disease: past, present and future.
        Ther Adv Respir Dis. 2008; 2: 319-338
        • Churg A
        • Wright JL
        • Tazelaar HD.
        Acute exacerbations of fibrotic interstitial lung disease.
        Histopathology. 2011; 58: 525-530
        • Coultas DB
        • Zumwalt RE
        • Black WC
        • Sobonya RE.
        The epidemiology of interstitial lung diseases.
        Am J Respir Crit Care Med. 1994; 150: 967-972
        • Meyer KC.
        Diagnosis and management of interstitial lung disease.
        Transl Respir Med. 2014; 2: 4
        • Raghu G
        • Nyberg F
        • Morgan G.
        The epidemiology of interstitial lung disease and its association with lung cancer.
        Br J Cancer. 2004; 91: S3-10
        • Leuschner G
        • Behr J.
        Acute exacerbation in interstitial lung disease.
        Front Med (Lausanne). 2017; 4: 176
        • Charokopos A
        • Moua T
        • Ryu JH
        • Smischney NJ.
        Acute exacerbation of interstitial lung disease in the intensive care unit.
        World J Crit Care Med. 2022; 11: 22-32
        • Glazer CS
        • Newman LS.
        Occupational interstitial lung disease.
        Clin Chest Med. 2004; 25: 467-478
        • Selman M
        • Pardo A
        • King TE
        Hypersensitivity pneumonitis.
        Am J Respir Crit Care Med. 2012; 186: 314-324
        • Sirajuddin A
        • Kanne JP.
        Occupational lung disease.
        J Thorac Imaging. 2009; 24: 310-320
        • Sauler M
        • Gulati M.
        Newly recognized occupational and environmental causes of chronic terminal airways and parenchymal lung disease.
        Clin Chest Med. 2012; 33: 667-680
        • Koster MA
        • Thomson CC
        • Collins BF
        • Jenkins AR
        • Ruminjo JK
        • Raghu G.
        Diagnosis of Hypersensitivity Pneumonitis in Adults, 2020 Clinical Practice Guideline: Summary for Clinicians.
        Ann Am Thorac Soc. 2021; 18: 559-566
        • Dodia N
        • Amariei D
        • Kenaa B
        • et al.
        A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.
        Respir Med. 2021; 179106333
        • Douglas WW
        • Tazelaar HD
        • Hartman TE
        • et al.
        Polymyositis-dermatomyositis-associated interstitial lung disease.
        Am J Respir Crit Care Med. 2001; 164: 1182-1185
        • Nagai S
        • Kitaichi M
        • Itoh H
        • Nishimura K
        • Izumi T
        • Colby TV
        Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP.
        Eur Respir J. 1998; 12: 1010-1019
        • Coultas DB
        • Hughes MP.
        Accuracy of mortality data for interstitial lung diseases in New Mexico, USA.
        Thorax. 1996; 51: 717-720
        • Song JW
        • Hong SB
        • Lim CM
        • Koh Y
        • Kim DS.
        Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.
        Eur Respir J. 2011; 37: 356-363
        • Dotan Y
        • Vaidy A
        • Shapiro WB
        • et al.
        Effect of acute exacerbation of idiopathic pulmonary fibrosis on lung transplantation outcome.
        Chest. 2018; 154: 818-826
        • Collard HR
        • Ryerson CJ
        • Corte TJ
        • et al.
        Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report.
        Am J Respir Crit Care Med. 2016; 194: 265-275
        • Kim DS
        • Park JH
        • Park BK
        • Lee JS
        • Nicholson AG
        • Colby T.
        Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features.
        Eur Respir J. 2006; 27: 143-150
        • Atkins CP
        • Loke YK
        • Wilson AM.
        Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials.
        Respir Med. 2014; 108: 376-387
        • Collard HR
        • Yow E
        • Richeldi L
        • Anstrom KJ
        • Glazer C
        • IPFnet investigators
        Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials.
        Respir Res. 2013; 14: 73
        • Kondoh Y
        • Taniguchi H
        • Ebina M
        • et al.
        Risk factors for acute exacerbation of idiopathic pulmonary fibrosis–extended analysis of pirfenidone trial in Japan.
        Respir Investig. 2015; 53: 271-278
        • Kondoh Y
        • Taniguchi H
        • Katsuta T
        • et al.
        Risk factors of acute exacerbation of idiopathic pulmonary fibrosis.
        Sarcoidosis Vasc Diffuse Lung Dis. 2010; 27: 103-110
        • Simon-Blancal V
        • Freynet O
        • Nunes H
        • et al.
        Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.
        Respiration. 2012; 83: 28-35
        • Collard HR
        • Moore BB
        • Flaherty KR
        • et al.
        Acute exacerbations of idiopathic pulmonary fibrosis.
        Am J Respir Crit Care Med. 2007; 176: 636-643
        • Luppi F
        • Cerri S
        • Taddei S
        • Ferrara G
        • Cottin V.
        Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review.
        Intern Emerg Med. 2015; 10: 401-411
        • Bando M
        • Ohno S
        • Hosono T
        • et al.
        Risk of acute exacerbation after video-assisted thoracoscopic lung biopsy for interstitial lung disease.
        J Bronchology Interv Pulmonol. 2009; 16: 229-235
        • Moua T
        • Westerly BD
        • Dulohery MM
        • Daniels CE
        • Ryu JH
        • Lim KG.
        Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis.
        Chest. 2016; 149: 1205-1214
        • Arcadu A
        • Moua T.
        Bronchoscopy assessment of acute respiratory failure in interstitial lung disease.
        Respirology. 2017; 22: 352-359
        • Suzuki A
        • Kondoh Y
        • Brown KK
        • et al.
        Acute exacerbations of fibrotic interstitial lung diseases.
        Respirology. 2020; 25: 525-534
        • Caminati A
        • Harari S.
        Which prognostic indicator should we use for clinical practice in the initial evaluation and follow-up of IIP: should we depend on PFT, HRCT or...what?.
        Sarcoidosis Vasc Diffuse Lung Dis. 2005; 22: S24-S30
        • Martinez FJ.
        Pulmonary function testing in idiopathic interstitial pneumonias.
        Proc Am Thorac Soc. 2006; 3: 315-321
        • Disayabutr S
        • Calfee CS
        • Collard HR
        • Wolters PJ.
        Interstitial lung diseases in the hospitalized patient.
        BMC Med. 2015; 13: 245
        • Voelkel NF
        • Quaife RA
        • Leinwand LA
        • et al.
        Right ventricular function and failure.
        Circulation. 2006; 114: 1883-1891
        • Wilcox SR
        • Kabrhel C
        • Channick RN.
        Pulmonary hypertension and right ventricular failure in emergency medicine.
        Ann Emerg Med. 2015; 66: 619-628
        • Parshall MB
        • Schwartzstein RM
        • Adams L
        • et al.
        An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea.
        Am J Respir Crit Care Med. 2012; 185: 435-452
        • Morice AH
        • Millqvist E
        • Bieksiene K
        • et al.
        ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.
        Eur Respir J. 2020; 551901136
        • Bohadana A
        • Izbicki G
        • Kraman SS.
        Fundamentals of lung auscultation.
        N Engl J Med. 2014; 370: 744-751
        • Miller WT.
        Chest radiographic evaluation of diffuse infiltrative lung disease: review of a dying art.
        Eur J Radiol. 2002; 44: 182-197
        • Homma S
        • Bando M
        • Azuma A
        • et al.
        Japanese guideline for the treatment of idiopathic pulmonary fibrosis.
        Respir Investig. 2018; 56: 268-291
        • Wijsenbeek M
        • Cottin V.
        Spectrum of fibrotic lung diseases.
        N Engl J Med. 2020; 383: 958-968
        • Azadeh N
        • Moua T
        • Baqir M
        • Ryu JH.
        Treatment of acute exacerbations of interstitial lung disease.
        Expert Rev Respir Med. 2018; 12: 309-313
        • Lynch DA
        • Sverzellati N
        • Travis WD
        • et al.
        Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
        Lancet Respir Med. 2018; 6: 138-153
        • Galioto F
        • Palmucci S
        • Astuti GM
        • et al.
        Complications in idiopathic pulmonary fibrosis: focus on their clinical and radiological features.
        Diagnostics (Basel). 2020; 10: 450
        • Baratella E
        • Fiorese I
        • Marrocchio C
        • Salton F
        • Cova MA.
        Imaging review of the lung parenchymal complications in patients with IPF.
        Medicina (Kaunas). 2019; 55: 613
        • Raghu G.
        Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient?.
        Am J Respir Crit Care Med. 1995; 151: 909-914
        • Gutierrez M
        • Soto-Fajardo C
        • Pineda C
        • et al.
        Ultrasound in the assessment of interstitial lung disease in systemic sclerosis: a systematic literature review by the OMERACT Ultrasound Group.
        J Rheumatol. 2020; 47: 991-1000
        • Yioe V
        • Phillips G
        • Spencer LG.
        Interstitial lung disease on the acute take for the non-respiratory physician.
        Clin Med (Lond). 2021; 21: e584-e590
        • Millan-Billi P
        • Serra C
        • Alonso Leon A
        • Castillo D
        Comorbidities, complications and non-pharmacologic treatment in idiopathic pulmonary fibrosis.
        Med Sci (Basel). 2018; 6: 59
        • Meyer KC.
        Lung transplantation.
        F1000Prime Rep. 2013; 5: 16
        • Travis WD
        • Matsui K
        • Moss J
        • Ferrans VJ.
        Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia.
        Am J Surg Pathol. 2000; 24: 19-33
        • Kondoh Y
        • Taniguchi H
        • Yokoi T
        • et al.
        Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
        Eur Respir J. 2005; 25: 528-533
        • Jang HJ
        • Yong SH
        • Leem AY
        • et al.
        Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department.
        Sci Rep. 2021; 11: 5762
        • Richeldi L
        • Davies HR
        • Ferrara G
        • Franco F.
        Corticosteroids for idiopathic pulmonary fibrosis.
        Cochrane Database Syst Rev. 2003; CD002880
        • Homma S
        • Sakamoto S
        • Kawabata M
        • et al.
        Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia.
        Intern Med. 2005; 44: 1144-1150
        • Tachikawa R
        • Tomii K
        • Ueda H
        • et al.
        Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
        Respiration. 2012; 83: 20-27
        • Nanki N
        • Fujita J
        • Yamaji Y
        • et al.
        Nonspecific interstitial pneumonia/fibrosis completely recovered by adding cyclophosphamide to corticosteroids.
        Intern Med. 2002; 41: 867-870
        • Kawamura K
        • Ichikado K
        • Suga M
        • Yoshioka M.
        Efficacy of azithromycin for treatment of acute exacerbation of chronic fibrosing interstitial pneumonia: a prospective, open-label study with historical controls.
        Respiration. 2014; 87: 478-484
        • Shimizu Y
        • Sunaga N
        • Dobashi K
        • et al.
        Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study.
        BMC Infect Dis. 2009; 9: 47
        • Hubbard R
        • Venn A
        • Lewis S
        • Britton J.
        Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
        Am J Respir Crit Care Med. 2000; 161: 5-8
        • Martin MJ
        • Moua T.
        Mechanical ventilation and predictors of in-hospital mortality in fibrotic interstitial lung disease with acute respiratory failure: a cohort analysis through the paradigm of acute respiratory distress syndrome.
        Crit Care Med. 2020; 48: 993-1000
        • Mizuno Y
        • Iwata H
        • Shirahashi K
        • et al.
        The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer.
        Eur J Cardiothorac Surg. 2012; 41: e161-e165
        • Faverio P
        • de Giacomi F
        • Sardella L
        • et al.
        Management of acute respiratory failure in interstitial lung diseases: overview and clinical insights.
        BMC Pulm Med. 2018; 18: 70
        • Vianello A
        • Arcaro G
        • Battistella L
        • et al.
        Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis.
        J Crit Care. 2014; 29: 562-567
        • Yokoyama T
        • Kondoh Y
        • Taniguchi H
        • et al.
        Noninvasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis.
        Intern Med. 2010; 49: 1509-1514
        • Yokoyama T
        • Tsushima K
        • Yamamoto H
        • Koizumi T
        • Kubo K.
        Potential benefits of early continuous positive pressure ventilation in patients with rapidly progressive interstitial pneumonia.
        Respirology. 2012; 17: 315-321
        • Vianello A
        • Arcaro G
        • Molena B
        • et al.
        High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis.
        Ther Adv Respir Dis. 2019; 13 (1753466619847130)
        • Omote N
        • Matsuda N
        • Hashimoto N
        • et al.
        High-flow nasal cannula therapy for acute respiratory failure in patients with interstitial pneumonia: a retrospective observational study.
        Nagoya J Med Sci. 2020; 82: 301-313
        • Faverio P
        • de Giacomi F
        • Bonaiti G
        • et al.
        Management of chronic respiratory failure in interstitial lung diseases: overview and clinical insights.
        Int J Med Sci. 2019; 16: 967-980
        • Horio Y
        • Takihara T
        • Niimi K
        • et al.
        High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: a case series.
        Respir Investig. 2016; 54: 125-129
        • Aliberti S
        • Messinesi G
        • Gamberini S
        • et al.
        Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases.
        BMC Pulm Med. 2014; 14: 194
        • Vahdatpour CA
        • Pichler A
        • Palevsky HI
        • Kallan MJ
        • Patel NB
        • Kinniry PA.
        Interstitial lung disease associated acute respiratory failure requiring invasive mechanical ventilation: a retrospective analysis.
        Open Respir Med J. 2020; 14: 67-77
        • Fernández-Pérez ER
        • Yilmaz M
        • Jenad H
        • et al.
        Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease.
        Chest. 2008; 133: 1113-1119
        • Gaudry S
        • Vincent F
        • Rabbat A
        • et al.
        Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia.
        J Thorac Cardiovasc Surg. 2014; 147: 47-53
        • Vincent F
        • Gonzalez F
        • Do CH
        • Clec'h C
        • Cohen Y.
        Invasive mechanical ventilation in patients with idiopathic pulmonary fibrosis or idiopathic non-specific interstitial pneumonia.
        Intern Med. 2011; 50 (author reply 175): 173-174
        • Marchioni A
        • Tonelli R
        • Ball L
        • et al.
        Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?.
        Crit Care. 2018; 22: 80
        • Terragni PP
        • Rosboch G
        • Tealdi A
        • et al.
        Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome.
        Am J Respir Crit Care Med. 2007; 175: 160-166
        • Brower RG
        • Lanken PN
        • MacIntyre N
        • et al.
        Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.
        N Engl J Med. 2004; 351: 327-336
        • Trudzinski FC
        • Kaestner F
        • Schäfers HJ
        • et al.
        Outcome of patients with interstitial lung disease treated with extracorporeal membrane oxygenation for acute respiratory failure.
        Am J Respir Crit Care Med. 2016; 193: 527-533
        • Usagawa Y
        • Komiya K
        • Yamasue M
        • Fushimi K
        • Hiramatsu K
        • Kadota JI.
        Efficacy of extracorporeal membrane oxygenation for acute respiratory failure with interstitial lung disease: a case control nationwide dataset study in Japan.
        Respir Res. 2021; 22: 211
        • Abrams D
        • Javidfar J
        • Farrand E
        • et al.
        Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study.
        Crit Care. 2014; 18: R38
        • Marasco SF
        • Lukas G
        • McDonald M
        • McMillan J
        • Ihle B.
        Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients.
        Heart Lung Circ. 2008; 17: S41-S47
        • Kapnadak SG
        • Raghu G.
        Lung transplantation for interstitial lung disease.
        Eur Respir Rev. 2021; 30210017
        • Leard LE
        • Holm AM
        • Valapour M
        • et al.
        Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation.
        J Heart Lung Transplant. 2021; 40: 1349-1379
        • Kotloff RM
        • Thabut G.
        Lung transplantation.
        Am J Respir Crit Care Med. 2011; 184: 159-171
        • Yusen RD
        • Edwards LB
        • Dipchand AI
        • et al.
        The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant.
        J Heart Lung Transplant. 2016; 35: 1170-1184